483PD Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): mature analysis of overall survival (OS) in the New EPOC randomised controlled trial.
Authors
Bridgewater, JPugh, S
Whitehead, A
Stanton, L
Eminton, Z
Mellor, J
Allen, A
Finch-Jones, M
Falk, S
Iveson, T
Rees, M
Valle, Juan W
Hornbuckle, J
Hickish, T
Cunningham, D
Maughan, T
Garden, J
Griffiths, G
Primrose, J
Affiliation
Oncology, UCL Cancer Institute/Paul O’Gorman Building, LondonIssue Date
2017-09
Metadata
Show full item recordCitation
483PD Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): mature analysis of overall survival (OS) in the New EPOC randomised controlled trial. 2017, 28(suppl_5): Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx393.010Additional Links
http://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx393.010/4109782/483PDPerioperative-chemotherapy-with-or-withoutType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx393.010